Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:1564-1570
Published online before print March 12, 2009, doi: 10.1161/STROKEAHA.108.532325
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/5/1564    most recent
STROKEAHA.108.532325v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bineau, S.
Right arrow Articles by Tzourio, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bineau, S.
Right arrow Articles by Tzourio, C.
Related Collections
Right arrow Primary prevention
Right arrow Cerebrovascular disease/stroke
Right arrow Epidemiology

(Stroke. 2009;40:1564.)
© 2009 American Heart Association, Inc.


Original Contributions

Framingham Stroke Risk Function in a Large Population-Based Cohort of Elderly People

The 3C Study

Sébastien Bineau, MD, Msc; Carole Dufouil, PhD; Catherine Helmer, MD, PhD; Karen Ritchie, PhD; Jean-Philippe Empana, MD, PhD; Pierre Ducimetière, PhD; Annick Alpérovitch, MD, Msc; Marie Germaine Bousser, MD Christophe Tzourio, MD, PhD

From INSERM U708 "Neuroepidemiology" (S.B., C.D., A.A., C.T.), Paris; UPMC Univ Paris 06 (S.B., C.D., A.A., C.T.), Paris; INSERM U593 and Université Bordeaux 2 (C.H.), Bordeaux; INSERM U888 (K.R.), Montpellier; INSERM U909 (J.-P.E., P.D.), Villejuif; and the Department of Neurology (M.G.B., C.T.), Hôpital Lariboisière, Paris, France.

Correspondence to Dr Christophe Tzourio, INSERM U708, Hôpital de la Salpêtrière, 47, boulevard de l’Hôpital, 75651 PARIS CEDEX 13, France. E-mail tzourio{at}chups.jussieu.fr

Background and Purpose— External validation of the Framingham stroke risk function has been rarely performed. We assessed its predictive ability in a population-based cohort of French elderly.

Methods— The sample comprised 6913 subjects from the 3C Study, aged 65 to 84 at baseline, who were followed up to 6 years. Predictive accuracy of the original Framingham stroke risk function was assessed in a 3-step procedure: comparison between the Framingham and 3C cohorts of the prevalence of selected risk factors and the associated relative risks (RR) for stroke, comparison of the predicted to the observed number of stroke events (calibration), and ability to separate high-risk from low-risk participants (discrimination). We also compared predictive performances of the original Framingham, the recalibrated Framingham, and the local stroke risk functions.

Results— During follow-up, 110 incident strokes occurred. For most risk factors, RRs were comparable between the 2 cohorts, except for age in women. The original Framingham stroke risk function applied to the 3C cohort overestimated the 6-year absolute risk for stroke by a factor of 3.7 for men and 4.4 for women. However, the recalibrated Framingham and 3C functions did not show any over- or underestimation of stroke risk. The 3 stroke risk functions (original, recalibrated, and 3C) provided acceptable discrimination with areas under the ROC curve ranging from 0.67 to 0.73.

Conclusions— The original Framingham stroke risk function strongly overestimated the stroke risk for 3C participants. Derived Framingham stroke score sheets should not be directly used by physicians in the French elderly population.


Key Words: stroke • risk • aging • cohort studies